DAFNA Capital Management LLC
83 holdingsFiling period: 2026-03-31Current AUM: $534.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RVMD | REVOLUTION MEDICINES INC | 580.7K | $56.5M | $108.9M | 20.39% | -23,836 | 2026-03-31 |
| 2 | XBI | SPDR S&P BIOTECH ETF | 318.5K | $40.7M | $46.8M | 8.77% | -18,000 | 2026-03-31 |
| 3 | STXS | STEREOTAXIS INC | 13.68M | $25.2M | $17.2M | 3.23% | -- | 2026-03-31 |
| 4 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | 978.5K | $21.0M | $21.0M | 3.93% | -20,700 | 2026-03-31 |
| 5 | ATRC | ATRICURE INC | 597.4K | $17.0M | $22.6M | 4.22% | -- | 2026-03-31 |
| 6 | IDYA | IDEAYA BIOSCIENCES INC | 476.7K | $15.9M | $16.9M | 3.17% | -30,000 | 2026-03-31 |
| 7 | XENE | XENON PHARMACEUTICALS INC | 250.8K | $14.6M | $15.7M | 2.94% | -37,167 | 2026-03-31 |
| 8 | CYTK | CYTOKINETICS INC | 217.5K | $14.3M | $16.8M | 3.14% | -153,500 | 2026-03-31 |
| 9 | CMPS | COMPASS PATHWAYS PLC | 2.42M | $13.4M | $27.5M | 5.14% | +1.61M | 2026-03-31 |
| 10 | NKTR | NEKTAR THERAPEUTICS | 165.2K | $11.9M | $11.7M | 2.19% | +90.2K | 2026-03-31 |
| 11 | IBB | ISHARES NASDAQ BIOTECH INDX | 62.1K | $10.5M | $11.6M | 2.17% | -6,000 | 2026-03-31 |
| 12 | RCUS | ARCUS BIOSCIENCES INC | 443.8K | $9.6M | $12.5M | 2.34% | +12.5K | 2026-03-31 |
| 13 | NBIX | NEUROCRINE BIOSCIENCES INC | 70.6K | $9.3M | $11.8M | 2.21% | -- | 2026-03-31 |
| 14 | LRMR | LARIMAR THERAPEUTICS INC | 2.03M | $9.1M | $7.8M | 1.45% | +1.09M | 2026-03-31 |
| 15 | BCAX | BICARA THERAPEUTICS INC | 421.7K | $8.4M | $11.4M | 2.14% | +160.2K | 2026-03-31 |
| 16 | AXGN | AXOGEN INC | 250.0K | $8.3M | $10.6M | 1.98% | -226,866 | 2026-03-31 |
| 17 | — | BIOHAVEN LTD | 845.7K | $7.2M | $7.2M | 1.34% | -109,500 | 2026-03-31 |
| 18 | TNDM | TANDEM DIABETES CARE INC | 355.2K | $6.8M | $6.9M | 1.30% | -- | 2026-03-31 |
| 19 | DNLI | DENALI THERAPEUTICS INC | 318.5K | $6.1M | $7.3M | 1.37% | -- | 2026-03-31 |
| 20 | ASND | ASCENDIS PHARMA A/S | 4.00M | $5.9M | $6.3M | 1.18% | -- | 2026-03-31 |
| 21 | IPSC | CENTURY THERAPEUTICS INC | 2.43M | $5.5M | $4.9M | 0.92% | -359,233 | 2026-03-31 |
| 22 | DXCM | DEXCOM INC | 86.3K | $5.4M | $7.2M | 1.35% | -2,000 | 2026-03-31 |
| 23 | KALV | KALVISTA PHARMACEUTICALS INC | 267.4K | $5.4M | $5.4M | 1.01% | -89,400 | 2026-03-31 |
| 24 | ASND | ASCENDIS PHARMA A/S | 23.2K | $5.3M | $5.7M | 1.06% | -5,000 | 2026-03-31 |
| 25 | MBX | MBX BIOSCIENCES INC | 175.5K | $5.2M | $11.6M | 2.17% | +10.2K | 2026-03-31 |
← Scroll →
Page 1 of 4